ELII: TP508: A New Drug for Mitigating Lethal Effects of Radiation Exposure

Project: Research project

Project Details

StatusFinished
Effective start/end date10/1/1210/31/17

Funding

  • Chrysalis BioTechnology ( Award #5R44AI08613506): $1,157,237.00